Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MACSiMiSE-BRAIN: Metformin add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination and Neurodegeneration: a Phase II Placebo-controlled Randomized Clinical Trial

NCT05893225 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT05893225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05893225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MACSiMiSE-BRAIN: Metformin add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination and Neurodegeneration: a Phase II Placebo-controlled Randomized Clinical Trial
Lead sponsor
University Hospital, Antwerp
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 23, 2023
Completion date
February 28, 2027
Enrollment
120 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, primary progressive multiple sclerosis, secondary-progressive multiple sclerosis